Form 8-K - Current report:
SEC Accession No. 0001193125-25-193450
Filing Date
2025-09-02
Accepted
2025-09-02 08:30:25
Documents
12
Period of Report
2025-08-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d95745d8k.htm   iXBRL 8-K 23273
  Complete submission text file 0001193125-25-193450.txt   140617

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA coya-20250829.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20250829_lab.xml EX-101.LAB 18734
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20250829_pre.xml EX-101.PRE 11722
14 EXTRACTED XBRL INSTANCE DOCUMENT d95745d8k_htm.xml XML 3766
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 251283089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)